Valuation: Inter Pharma

Market Cap 332.94Cr 10Cr 8.71Cr 8.12Cr 7.47Cr 14Cr 956.67Cr 14Cr 95Cr 37Cr 478.67Cr 38Cr 37Cr 1.59TCr P/E 2024
52.3x
P/E 2025 22.8x
Enterprise Value 344.87Cr 10Cr 9.03Cr 8.41Cr 7.74Cr 15Cr 990.95Cr 15Cr 99Cr 39Cr 495.82Cr 39Cr 38Cr 1.64TCr EV / Sales 2024
1.13x
EV / Sales 2025 1.31x
Free-Float
-
Yield 2024 *
-
Yield 2025 1.59%
11/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/03 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02/03 Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026 CI
12/11 Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients. CI
12/11 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/25/14 Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
13/25/13 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/25/16 Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal MT
16/25/16 Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited CI
01/25/01 Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation CI
25/25/25 Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/25/25 Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024 CI
14/24/14 Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
1 day+0.92%
1 week+1.85%
Current month+3.77%
1 month+23.32%
3 months+36.14%
6 months+27.91%
Current year+19.57%
1 week 5.2
Extreme 5.2
5.5
1 month 4.48
Extreme 4.48
5.5
Current year 3.68
Extreme 3.68
5.5
1 year 3.14
Extreme 3.14
5.5
3 years 2.02
Extreme 2.02
7.45
5 years 2.02
Extreme 2.02
14.46
10 years 1.62
Extreme 1.617581
15.14
Manager TitleAgeSince
Chief Executive Officer 56 01/02/2014
Director of Finance/CFO 56 23/06/2023
Compliance Officer 54 -
Director TitleAgeSince
Director/Board Member 51 14/06/2017
Director/Board Member 64 01/08/2020
Director/Board Member 56 01/02/2014
Date Insider Type Main position Quantity % Market Cap.
03/10/25 Buy

Chief Executive Officer

1,00,000 0.0165%
17/01/25 Buy

Chief Executive Officer

1,00,000 0.0165%
10/01/25 Buy

Chief Executive Officer

20,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.92%+1.85%+62.72%-24.89% 9.91Cr
+4.86%-3.32%+52.73%+160.26% 99TCr
+1.04%-2.99%+50.87%+52.38% 61TCr
+0.98%-6.49%+24.00%+66.66% 43TCr
+1.96%+0.83%+42.80%+37.60% 35TCr
-0.11%-4.07%+30.37%+39.73% 29TCr
+2.52%-8.36%+7.27%+10.32% 24TCr
+4.57%+5.21%+35.91%+67.64% 21TCr
-4.32%-12.94%-3.79%-44.56% 21TCr
-2.58%-0.73%+17.16%+67.46% 17TCr
Average +0.56%-3.08%+32.00%+43.26% 35.18TCr
Weighted average by Cap. +0.74%-3.95%+36.80%+75.03%

Financials

2024 2025
Net sales 191.19Cr 5.78Cr 5Cr 4.66Cr 4.29Cr 8.1Cr 549.38Cr 8.19Cr 55Cr 22Cr 274.88Cr 22Cr 21Cr 910.39Cr 221.41Cr 6.69Cr 5.79Cr 5.4Cr 4.97Cr 9.38Cr 636.19Cr 9.48Cr 63Cr 25Cr 318.32Cr 25Cr 25Cr 1.05TCr
Net income 3.73Cr 11.26L 10L 9L 8L 15.79L 11Cr 15.97L 1.07Cr 41.95L 5.36Cr 42.31L 41.38L 18Cr 12Cr 36.98L 32.03L 29.86L 27.46L 51.84L 35Cr 52.42L 3.51Cr 1.38Cr 18Cr 1.39Cr 1.36Cr 58Cr
Net Debt 21Cr 63.13L 54.68L 50.97L 46.88L 88.5L 60Cr 89.49L 5.99Cr 2.35Cr 30Cr 2.37Cr 2.32Cr 99Cr 12Cr 36.05L 31.22L 29.1L 26.77L 50.53L 34Cr 51.1L 3.42Cr 1.34Cr 17Cr 1.35Cr 1.32Cr 57Cr
Logo Inter Pharma
Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.
Employees
-
Date Price Change Volume
05/26/05 THB 5.500 +0.92% 8,72,570
04/26/04 THB 5.450 +0.93% 7,14,727
03/26/03 THB 5.400 +1.89% 3,14,173
31/26/31 THB 5.300 -0.93% 1,53,645
30/26/30 THB 5.350 -0.93% 3,65,513

Annual profits - Rate of surprise